Pharmaceutical News Wrap Up: October 2014

The Simmons Hanly Conroy pharmaceutical lawyers are dedicated to providing you with the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls and warning label changes, medical studies and other pharmaceutical news taking place across the globe .

    • Antidote for anticoagulant Pradaxa to be tested in Hamilton
      Read pharmaceutical news from Simmons Hanly ConroyFive Canadian hospitals are participating in a clinical trial that tests an antidote for Pradaxa, a blood-thinning medication that has been linked to serious bleeding. The drug’s manufacturer, Boehringer Igelheim, hopes the antidote will be able to reverse the serious effects of Pradaxa’s anticlotting abilities.


Simmons Support Team
Simmons Hanly ConroyWritten by:

Editorial Team

The Simmons Hanly Conroy Editorial Team consists of journalists, writers and editors who strive to deliver accurate and useful information to families needing legal help. Our team works alongside the firm's attorneys and shareholders, as well as with medical professionals and other specialists, to keep all information relevant and helpful.